These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 17297382

  • 1. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Jespers V, Buvé A, Van Damme L.
    Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
    [Abstract] [Full Text] [Related]

  • 2. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM, Mayer KH, Maslankowski L, Hoesley C, Justman J, Gai F, Mauck C, Absalon J, Morrow K, Mâsse B, Soto-Torres L, Kwiecien A.
    AIDS; 2006 May 12; 20(8):1109-16. PubMed ID: 16691061
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
    van der Straten A, Napierala S, Cheng H, Mauck C, Depineres T, Dhlakama P, Thompson M, Chipato T, Hammond N, Padian N.
    Contraception; 2007 Nov 12; 76(5):389-99. PubMed ID: 17963865
    [Abstract] [Full Text] [Related]

  • 4. Male tolerance of ACIDFORM gel.
    Schwartz JL, Poindexter A, Schmitz SW, Mauck C, Callahan MM.
    Contraception; 2005 Jun 12; 71(6):443-6. PubMed ID: 15914134
    [Abstract] [Full Text] [Related]

  • 5. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 12; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 6. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.
    Schwartz JL, Mauck C, Lai JJ, Creinin MD, Brache V, Ballagh SA, Weiner DH, Hillier SL, Fichorova RN, Callahan M.
    Contraception; 2006 Aug 12; 74(2):133-40. PubMed ID: 16860051
    [Abstract] [Full Text] [Related]

  • 7. Safety evaluation of 1% tenofovir gel in healthy men.
    Schwartz JL, Poindexter A, Wheeless A, Mauck CK, Callahan MM.
    Int J STD AIDS; 2009 Jun 12; 20(6):384-6. PubMed ID: 19451321
    [Abstract] [Full Text] [Related]

  • 8. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS, Ngoh N, Roddy R, Lai JJ, Linton K, Mauck C.
    Contraception; 2007 Sep 12; 76(3):245-9. PubMed ID: 17707724
    [Abstract] [Full Text] [Related]

  • 9. Fourteen-day safety and acceptability study of the universal placebo gel.
    Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM.
    Contraception; 2007 Feb 12; 75(2):136-41. PubMed ID: 17241844
    [Abstract] [Full Text] [Related]

  • 10. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
    Malonza IM, Mirembe F, Nakabiito C, Odusoga LO, Osinupebi OA, Hazari K, Chitlange S, Ali MM, Callahan M, Van Damme L.
    AIDS; 2005 Dec 02; 19(18):2157-63. PubMed ID: 16284466
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
    Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.
    Contraception; 2009 Nov 02; 80(5):484-92. PubMed ID: 19835725
    [Abstract] [Full Text] [Related]

  • 12. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb 02; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 13. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
    Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, Musara P, Mkandawire N, Moench T, Coletti A, Soto-Torres L, Karim SA, HPTN 035 Study Team.
    J Acquir Immune Defic Syndr; 2013 May 01; 63(1):120-5. PubMed ID: 23334506
    [Abstract] [Full Text] [Related]

  • 14. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study.
    Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, Pymar H, Lai JJ, Callahan M.
    Contraception; 2001 Dec 01; 64(6):383-91. PubMed ID: 11834238
    [Abstract] [Full Text] [Related]

  • 15. Acceptability of Carraguard vaginal gel use among Thai couples.
    Whitehead SJ, Kilmarx PH, Blanchard K, Manopaiboon C, Chaikummao S, Friedland B, Achalapong J, Wankrairoj M, Mock P, Thanprasertsuk S, Tappero JW.
    AIDS; 2006 Nov 14; 20(17):2141-8. PubMed ID: 17086053
    [Abstract] [Full Text] [Related]

  • 16. Cellulose sulfate: tolerance and acceptability of penile application.
    Mauck C, Frezieres R, Walsh T, Robergeau K, Callahan M.
    Contraception; 2001 Dec 14; 64(6):377-81. PubMed ID: 11834237
    [Abstract] [Full Text] [Related]

  • 17. Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial.
    Lacey CJ, Woodhall S, Qi Z, Sawant S, Cowen M, McCormack S, Jiang S.
    Int J STD AIDS; 2010 Oct 14; 21(10):714-7. PubMed ID: 21139151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Male tolerance study of 1% C31G.
    Mauck CK, Frezieres RG, Walsh TL, Schmitz SW, Callahan MM, Bax R.
    Contraception; 2004 Sep 14; 70(3):221-5. PubMed ID: 15325891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.